CS MEDICA is selling its Cannasen[®] CBD brand on Amazon Germany and Amazon Sweden but is not experiencing the sales uplift as expected. Hence, the roll-out to France, Italy, and other countries has been on hold.

To intensify the company's presence on Amazon, CS MEDICA has decided not to extend their existing contract with their current Amazon service provider Ampilio.

Heidi Ahlefeldt-Laurvig, CMO & CGO comments:

"Ampilio has done a great job helping us launch on both the Swedish and German Amazon; however, we experience products containing CBD need a different strategy and communication. The speed to market has been too slow; consequently, we agreed to move our partnership to Incubeta Maze-One, a preferred Amazon partner like Ampilio, but who is familiar working with CBD brands on Amazon."

Ulrik Grevenkop-Castenskiold, Managing Director, Incubeta Maze-One Nordic continues:

"We work with several Nordic brands within personal care, including CBD-based products, where we see an increasing sales potential in Europe. Selling CBD-based products on Amazon comes with certain compliance demands that require special solutions and communication tactics. We look forward to working with CS MEDICA to build and grow Amazon as a sales channel."

A revised strategy and an intensive launch plan are being executed in September/October. The aim is to grow awareness of the Cannasen® CBD brand and capture market shares across Europe, especially in the larger Amazon markets such as Germany, the UK, France, and Italy. For Spain, a roll-out will be either with Incubeta Maze-One or a preferred distributor.